Skip to main content

Advertisement

Log in

Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

End-stage renal disease (ESRD) and acquired renal cystic disease associated with dialysis are known risk factors of papillary renal cell carcinoma (pRCC); however, it is not known whether renal insufficiency alone is a risk factor for pRCC. Our aim was to test whether renal insufficiency is associated with an increased preponderance of pRCC.

Methods

Retrospective review of institutional database to identify all patients who underwent extirpative renal surgery for renal cell carcinoma (RCC) with complete records from 1992 to 2012. We excluded those patients with preoperative ESRD as defined by GFR < 15 mL/min/1.73 m2. The dependent variable was histologic RCC subtype. Independent variables included demographic data, comorbidities, and renal functional data. Multivariate analysis by binary logistic regression was used to determine factors that independently were associated with pRCC development.

Results

A total of 1,226 patients met inclusion criteria, of which 15 % were pRCC. There was a positive association between likelihood of pRCC histology of RCC and increasing preoperative chronic kidney disease (CKD) stage (p = 0.021). Multivariate regression analysis indicated that male gender, race, and declining renal function categorized both by GFR and CKD stage were independently associated with a higher likelihood of pRCC histology as compared to other RCC histology.

Conclusions

Within a large cohort of patients with a diagnosis of RCC, declining renal function was independently associated with an increased likelihood of pRCC histology. This finding and the available molecular evidence indicating protein expression similarity between pRCC and resident stem cells, which appear to be upregulated with kidney damage, suggest a possible causal relationship between renal injury and pRCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63:11–30

    Article  PubMed  Google Scholar 

  2. Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205

    Article  PubMed  CAS  Google Scholar 

  3. Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373:1119–1132

    Article  PubMed  CAS  Google Scholar 

  4. Schmidt L, Junker K, Nakaigawa N et al (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18:2343–2350

    Article  PubMed  CAS  Google Scholar 

  5. Schmidt LS, Nickerson ML, Angeloni D et al (2004) Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol 172:1256–1261

    Article  PubMed  Google Scholar 

  6. Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207

    Article  PubMed  Google Scholar 

  7. Bussolati B, Bruno S, Grange C et al (2005) Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166:545–555

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Schwartz JDDFH JM, Wilson GD, Wolforth SC, Rooney MT, Wei L, Zhang PL (2013) CD133 Staining detects acute kidney injury and differentiates clear cell papillary renal cell carcinoma from other renal tumors. ISRN Biomark 2013, 8

  9. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    Article  PubMed  PubMed Central  Google Scholar 

  10. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147

    Article  PubMed  Google Scholar 

  11. Campbell SCLBR (2012) Malignant renal tumors. In: Wein AJ (ed) Campbell-Walsh urology, vol 3, 10th edn. Elsevier, Philadelphia PA, p 4320

    Google Scholar 

  12. Ximing J, Yang KD, Jia L, Gersbach E, Lin F, Shen S, Teh BT (2013) Is papillary renal cell carcinoma derived from proximal convoluted tubules?. United States and Canadian Academy of Pathology Annual Meeting, Baltimore, MA

    Google Scholar 

  13. Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578

    Article  PubMed  Google Scholar 

  14. Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. J Am Med Assoc 290:199–206

    Article  Google Scholar 

  15. Fryzek JP, Poulsen AH, Johnsen SP et al (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92:1302–1306

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358

    Article  PubMed  Google Scholar 

  17. Ljungberg B, Campbell SC, Choi HY et al (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615–621

    Article  PubMed  Google Scholar 

  18. McCredie M, Pommer W, McLaughlin JK et al (1995) International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345–349

    Article  PubMed  CAS  Google Scholar 

  19. Park JH, Kim YO, Park JH et al (2000) Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis. Korean J Intern Med 15:51–55

    Article  PubMed  CAS  Google Scholar 

  20. Liu JS, Ishikawa I, Horiguchi T (2000) Incidence of acquired renal cysts in biopsy specimens. Nephron 84:142–147

    Article  PubMed  CAS  Google Scholar 

  21. Kasiske BL, Snyder JJ, Gilbertson DT et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4:905–913

    Article  PubMed  Google Scholar 

  22. Klatte T, Marberger M (2011) Renal cell carcinoma of native kidneys in renal transplant patients. Curr Opin Urol 21:376–379

    Article  PubMed  Google Scholar 

  23. Hofmann JN, Schwartz K, Chow WH et al (2013) The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control 24:167–174

    Article  PubMed  PubMed Central  Google Scholar 

  24. Weng PH, Hung KY, Huang HL et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6:1121–1128

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199–2210

    Article  PubMed  Google Scholar 

  26. Angelotti ML, Ronconi E, Ballerini L et al (2012) Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30:1714–1725

    Article  PubMed  CAS  Google Scholar 

  27. Kim K, Park BH, Ihm H et al (2011) Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Histol Histopathol 26:223–232

    PubMed  Google Scholar 

  28. Lindgren D, Bostrom AK, Nilsson K et al (2011) Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 178:828–837

    Article  PubMed  PubMed Central  Google Scholar 

  29. Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33:534–543

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

This retrospective human study has been approved by the Columbia University Medical Center institutional review board and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients have given their informed consent to be part of our institutional surgical registry of genitourinary cancers.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Solomon L. Woldu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Woldu, S.L., Weinberg, A.C., RoyChoudhury, A. et al. Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology. Int Urol Nephrol 46, 2127–2132 (2014). https://doi.org/10.1007/s11255-014-0780-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0780-4

Keywords

Navigation